Respiratory Tract Diseases

568 trials 207 recruiting

Filter these 568 trials by phase, country and sponsor.

Open in Search →

A study to test how well different doses of BI 3810477 are tolerated by healthy men Ended

2024-513419-28-00 Healthy volunteer trial 1 2024-10-22
A Phase 1b study of inhaled RCT1100 in Adults with Primary Ciliary Dyskinesia Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mu… Ended

2023-510521-14-00 Adults with Primary Ciliary Dyskinesia 3 2024-10-18
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Single and Multiple Do… Ended

2023-504426-19-00 Pulmonary fibrosis 1 2024-10-01
A trial to learn how AZD4604 acts in the body and how safe it is in adults with asthma Ended

2023-510291-32-00 Asthma 4 2024-09-26
Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dos… Ended

2023-506000-50-00 Adult Patients with Moderate-to-Severe Asthma Uncontrol 4 2024-09-26
Phase 2 study to evaluate the efficacy and safety of GSK3915393 in participants with Idiopathic Pulmonary Fibrosis (IPF) Ended

2023-509371-16-00 Idiopathic Pulmonary Fibrosis 4 2024-09-25
Optimizing the time of day of influenza vaccine administration in adults aged 60-85 years: A randomized controlled trial Ended

2024-513558-30-00 Influenza 6 2024-09-25
Comparison of the study drug CHF 1535 formulated with two different propellants to learn about drug levels in blood and safety after inhalat… Ended

2024-514247-28-00 Asthma 3 2024-09-17
A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis Ended

2023-510249-79-00 Progressive pulmonary fibrosis (PPF) 4 2024-09-10
A study to test whether BI 1819479 improves lung function in people with idiopathic pulmonary fibrosis (IPF). Ended

2023-508395-11-00 idiopathic pulmonary fibrosis 4 2024-09-10
A study to investigate the reactogenicity, safety, and immunogenicity of mRNA-1345 in pregnant women, and safety and immunogenicity in their… Ended

2023-505359-37-00 Respiratory syncytial virus 4 2024-09-03
A study on the immune response, safety and the occurrence of RSV-associated respiratory tract illness after administration of RSV OA vaccine… Ended

2023-509455-13-00 Respiratory Syncytial Virus Infections 11 2024-08-05
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants with Chronic Rhinosinusitis with Nasal Polyps on a Bac… Ended

2023-508231-31-00 Chronic Rhinosinusitis with Nasal Polyps 4 2024-07-24
A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the tr… Ended

2023-506185-31-00 Idiopathic pulmonary fibrosis (IPF) 10 2024-07-18
Randomized adaptive assessment of post COVID syndrome treatments (RAPID) Reducing Inflammatory Activity in Patients with post COVID Syndrome… Ended

2024-511628-16-00 Post Covid Syndrome (PCS) 4 2024-07-18
Evaluation of ELX/TEZ/IVA in Cystic Fibrosis Subjects 12 to Less Than 24 Months of Age Ended

2023-503230-49-00 Cystic Fibrosis 5 2024-07-16
Effect of NAL in participants with sleep disorders Ended

2023-508445-40-00 Obstructive Sleep Apnea 4 2024-07-01
A study to assess and compare safety and tolerability of 3 months treatment with salbutamol administered via MDI containing propellant HFA-1… Ended

2023-509001-76-00 Asthma 5 2024-07-01
An Open-label, Single-group, Three-period, Fixed-sequence, Phase I Study to Assess the Pharmacokinetics of AZD6793 Tablets When Administered… Ended

2023-509002-30-00 Chronic obstructive pulmonary disease 3 2024-06-25
A study to investigate the effect on lung function of an approved COPD treatment (BGF, with HFA propellant) compared to BGF formulated with… Ended

2023-506565-57-00 Moderate to Severe Chronic Obstructive Pulmonary Diseas 5 2024-06-21
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants with Severe Asthma (VALIANT) Ended

2023-507410-27-00 Severe Asthma 4 2024-06-19
A Proof-of-Concept study to assess the efficacy, safety and tolerability of itepekimab (anti-IL-33 mAb) in participants with non-cystic fibr… Ended

2023-508663-70-00 Bronchiectasis 4 2024-06-18
Comparison of the study drug CHF 1535 formulated with two different propellants to learn about drug levels in blood and safety after inhalat… Ended

2023-510171-59-00 Asthma and chronic obstructive pulmonary disease (COPD) 3 2024-06-17
A clinical study investigating OM-85-IN safety and tolerability in healthy volunteers and mild allergic asthma patients Ended

2022-503053-19-00 Mild allergic asthma 1 2024-06-14